Cargando…
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
Epidermal growth factor receptor (EGFR) is one of the most commonly altered genes in human cancer by way of over-expression, amplification, and mutation. Targeted inhibition of EGFR activity suppresses signal transduction pathways which control tumor cell growth, proliferation, and resistance to apo...
Autores principales: | Wykosky, Jill, Fenton, Tim, Furnari, Frank, Cavenee, Webster K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359794/ https://www.ncbi.nlm.nih.gov/pubmed/21192840 http://dx.doi.org/10.5732/cjc.010.10542 |
Ejemplares similares
-
Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks
por: Gomez, German G., et al.
Publicado: (2013) -
A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma
por: Read, Renee D., et al.
Publicado: (2013) -
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
por: Li, Jie, et al.
Publicado: (2014) -
Efficient synthesis of chloro-derivatives of sialosyllactosylceramide, and their enhanced inhibitory effect on epidermal growth factor receptor activation
por: KAWASHIMA, NAGAKO, et al.
Publicado: (2014) -
Nuclear epidermal growth factor receptor as a therapeutic target
por: Atwell, Benjamin, et al.
Publicado: (2023)